Welcome to Beth Israel Deaconess Hospital-Plymouth
The former Jordan Hospital becomes part of the Beth Israel Deaconess Medical Center family of hospitals
Jordan Hospital formally became Beth Israel Deaconess Hospital-Plymouth, part of the Beth Israel Deaconess Medical Center family of hospitals today. BID-Plymouth begins the new year with strengthened intensive care, neonatology and interventional cardiology services and short-term plans to expand programs in primary care, cancer and stroke care for the South Shore and Cape Cod.
On Jan. 1, BIDMC became the sole corporate member of Jordan Health Systems and Jordan Hospital. This structure is the same relationship that BIDMC has with its Milton and Needham hospitals.
This alliance will provide significant benefits to patients in the Jordan Hospital service area, offering access to world-class academic medical care in Plymouth and surrounding communities. Independent market research shows that patients and potential patients already place a high value on both Jordan Hospital and BIDMC, and feel that both can provide high quality health care.
“Today our hospital entered its 114th year of service to the community by becoming part of the Beth Israel Deaconess Medical Center family of hospitals,” said BID-Plymouth President and CEO Peter Holden. “Although our name has changed, our mission has not: To improve the health and well-being of our patients and community by providing a full continuum of health care services with excellence.”
“We are proud to welcome Beth Israel Deaconess Hospital-Plymouth to our family,” said BIDMC President and CEO Kevin Tabb, MD. “Our formal alliance strengthens our community network, and is fundamental to our long-standing philosophy to provide care in the right place at the right time.”
As part of the new relationship, local Atrius Health patients needing emergency care – or hospitalization for common inpatient medical problems – will have access to BID-Plymouth, where they will benefit from an integrated system of care, including easy access, up-to-date electronic connectivity with the care team and the hospital, and a coordination of treatment that will insure a quality health care experience.
The alliance also includes greater collaboration with the Harvard Medical Faculty Physicians at BIDMC, the practice that includes the medical center’s primary care and specialist physicians.
Transitions have been underway since the Massachusetts Public Health Council approved the relationship in October. Alan Lisbon, MD, associate chief of BIDMC’s Department of Anesthesia, Critical Care and Pain Medicine, has been serving as BID-Plymouth’s Critical Care Center’s Medical Director, with plans to add four additional BIDMC intensive care specialists in the coming months.
BIDMC neonatologist Barbara Shephard, MD, has been the medical director of the Continuing Care Nursery at The BirthPlace. She has been joined by associate director Maggie Everett, MD, and a team of eight additional neonatologists from BIDMC, caring around-the-clock, 7 days a week, for babies who need a little extra care and encouragement as they start out in life.
Later this spring, three BIDMC interventional cardiologists will join the team already in place in the BID-Plymouth cardiac catheterization lab, helping to provide both diagnostic and on-site interventional catheterization. In addition, three BIDMC thoracic surgeons will help to expand that program.
Coming in mid-January will be BIDMC TeleNet: Stroke, providing 24-7 access to the BIDMC’s stroke team through two-way video. Within 15 minutes of a patient’s arrival, a Plymouth-based physician will be able to get an assessment of a potential stroke from Boston-based experts. Patients needing advanced care will be quickly transported into Boston and returned home as soon as practical to receive local care.
BID-Plymouth will further expand the scope of its outstanding cancer services with BIDMC oncologists and surgeons collaborating with medical and radiation oncology teams to develop clinical pathways, the tools used by BIDMC’s multi-disciplinary cancer team to provide guide-evidenced-based patient care. The relationship will also expand an already robust menu of clinical trials on site in Plymouth and in Boston.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently ranks third in National Institutes of Health funding among independent hospitals nationwide.
The BIDMC health care team includes Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Health Care, Commonwealth Hematology-Oncology, Beth Israel Deaconess HealthCare, Community Care Alliance, and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Senior Life and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.
Beth Israel Deaconess Hospital-Plymouth is a not-for-profit organization serving 12 towns in Plymouth and Barnstable Counties. Established in 1901 as Jordan Hospital, it is a full-service, 155-bed acute care community hospital accredited by The Joint Commission, the College of American Pathologists, the American College of Surgeons Commission on Cancer, and the American College of Radiology.
275 Sandwich Street
Plymouth, MA 02360